MyFinsight
Home
Blog
About
Increase (decrease) in
accrued expenses and...
$58,968,000
(1045.05%↑ Y/Y)
Net income
$25,988,000
(-35.79%↓ Y/Y)
Depreciation and
amortization
$10,540,000
Change in contingent
consideration
-$6,652,000
Stock-based compensation
$4,084,000
(-33.89%↓ Y/Y)
Deferred income taxes
$3,975,000
Other
-$729,000
Net cash provided by
operating activities
$86,237,000
(73.42%↑ Y/Y)
Canceled cashflow
$24,699,000
Net increase in cash
and cash...
$78,605,000
(-33.75%↓ Y/Y)
Canceled cashflow
$7,632,000
Increase in inventory
$7,852,000
(285.87%↑ Y/Y)
Decrease in account
receivables
$6,432,000
(173.58%↑ Y/Y)
Increase in prepaid
expenses and other assets
$5,093,000
(182.05%↑ Y/Y)
Increase in accounts
payable
-$2,776,000
(-167.79%↓ Y/Y)
Change in fair value of
marketable securities
-$2,546,000
Proceeds from exercise of
stock options
$235,000
(-84.05%↓ Y/Y)
Net cash (used in)
provided by financing...
-$7,071,000
(-107.92%↓ Y/Y)
Net cash provided by
(used in) investing...
-$561,000
(97.25%↑ Y/Y)
Canceled cashflow
$235,000
Repurchase of common stock
$6,392,000
Payment of contingent
consideration liabilities
$606,000
Rou financing lease
fees
$177,000
Purchase of property,
plant, and equipment...
$561,000
(1544.10%↑ Y/Y)
Payment of employee
withholding taxes on vested...
$131,000
(-89.66%↓ Y/Y)
Back
Back
Cash Flow
CorMedix Inc. (CRMD)
CorMedix Inc. (CRMD)
source: myfinsight.com